Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease

Neuroscience Letters

Volumn 212, Issue 2, 1996, Pages 111-114

  Rezaie, Payam ^a   Cairns, Nigel J ^a   Chadwick, Andrew ^a   Lantos, Peter L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anti ubiquitin immunohistochemistry; Diffuse Lewy body disease; Lewy body; Neuritic plaque; Neurofibrillary tangle

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN STEM; CLINICAL ARTICLE; DEMENTIA; HUMAN; IMMUNOHISTOCHEMISTRY; LEWY BODY; LIMBIC CORTEX; NEUROFIBRILLARY TANGLE; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0030581111     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12775-0     Document Type: Article

References (23)

1. [1] Braak, H., Braak, E., Yilmazer, D., de Vos, R.A., Jansen, E.N., Bohl, J. and Jellinger, K., Amygdala pathology in Parkinson's disease, Acta Neuropathol., 88 (1994) 493-500.
2. [2] Dickson, D.W., Schmidt, M.L., Lee, V.M., Zhao, M.L., Yen, S.H. and Trojanowski, J.Q., Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease, Acta Neuropathol., 87 (1994) 269-276.
3. [3] Dickson, D.W., Ruan, D., Crystal, H., Mark, M.H., Davies, P., Kress, Y. and Yen, S.H., Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD, Neurology, 41 (1991) 1402-1409.
4. [4] Forno, L.S. and Langston, J.W., Lewy bodies and aging, J. Neuropathol. Neurosurg. Psychiatry, 49 (1990) 278.
5. [5] Gibb, W.R.G., Luthert, P.J., Janota, I. and Lantos, P.L., Cortical Lewy body dementia: clinical features and classification, J. Neurol. Neurosurg. Psychiatry, 52 (1989) 185-192.
6. [6] Hansen, L.A., Salmon, D., Galasko, D., Masliah, E., Katzman, R., DeTeresa, R., Thal, L., Pay, M.M., Hofstetter, R., Klauber, M., Rice, V., Butters, N. and Alford, M., The Lewy body variant of Alzheimer's disease: a clinical and pathological entity, Neurology, 40 (1990) 1-7.
7. [7] Hansen, L.A., Masliah E., Galasko, D. and Terry, R.D., Plaque-only Alzheimer's disease is usually the Lewy body variant, and vice versa, J. Neuropathol. Exp. Neurol., 52 (1993) 648-654.
8. [8] Hill, W.D., Lee, V.M., Hurtig, H.I., Murray, J.M. and Trojanowski, J.Q., Epitopes localised in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies, J. Comp. Neurol., 309 (1991) 150-160.
9. [9] Hughes, A.J., Daniel, S.E., Kilford, L. and Lees, A.J., Accuracy of clinical diagnosis of iodiopathic Parkinson's disease: a clinico-pathological study of 100 cases, J. Neurol. Neurosurg. Psychiatry, 55 (1992) 181-184.
10. [10] Hutchins, K.D., Wu, E., Kascsak, R. and Dickson, D.W., Spongioform change in diffuse Lewy body disease, J. Neuropathol. Neurosurg. Psychiatry, 51 (1992) 327.
11. [11] Kosaka, K., Matsushita, M., Oyanagi, S. and Mehraein, P., A clinico-neuropathological study of the Lewy body disease, Jpn. Psychiatry Neurol., 82 (1980) 292-311.
12. [12] Kuljis, R.O., Martin-Vassalo, P. and Peress, N., Lewy bodies in tyrosine hydroxylase synthesising neurons of the human cerebral cortex, Neurosci. Lett., 106 (1989) 49-54.
13. [13] Lennox, G., Lowe, J., Morell, K., Landen, M. and Mayer, R.J., Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease, J. Neurol. Neurosurg. Psychiatry, 52 (1989) 67-71.
14. [14] Lennox, G., Lowe, J., Landen, M., Byrne, J., Mayer, J. and Godwin-Austen, R.B., Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry, J. Neurol. Neurosurg. Psychiatry, 52 (1989) 1236-1247.
15. [15] Lippa, C.F., Smith, W. and Swearer, J.M., Alzheimer's disease and Lewy body disease: a comparative clinico-pathological study, Ann. Neurol., 35 (1994) 81-88.
16. [16] McKeith, I.G., Perry, R.H., Fairbairn, A.F., Jabeen, S. and Perry, E.K., Operational criteria for senile dementia of Lewy body type (SDLT), Psychol. Med., 22 (1992) 911-922.
17. [17] Mayer, R.J., Lowe, J., Lennox, G., Doherty, F. and Landen, M., Intermediate filaments and ubiquitin: a new thread in the understanding of chronic neurodegenerative diseases. In Alzheimer's Disease and Related Disorders, Alan R. Liss, London, 1989, pp. 809-818.
18. [18] Mirra, S.S., Heyman, A., McKeel, D., Sumi, S.M., Crain, B.J., Brownlee, L.M., Vogel, F.S., Hughes, J.P., van Belle, G. and Berg, L., The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology, 41 (1991) 479-486.
19. [18] Mirra, S.S., Hart, M.N. and Terry, R.D., Making the diagnosis of Alzheimer's disease: a primer for practising pathologists, Arch. Pathol. Lab. Med., 117 (1993) 132-144.
20. [19] Nishimura, M., Tomimoto, H., Suenaga, T., Kakamura, S., Namba, Y., Ikeda, K., Akiguchi, I. and Kimura, J., Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains, Brain Res., 634 (1994) 339-344.
21. [20] Perry, R.H., Irving, D., Blessed, G., Fairbairn, A. and Perry, E.K., Senile dementia of the Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly, J. Neurol. Sci., 95 (1990) 119-139.
22. [21] Schmidt, M.L., Murray, J., Lee, V.M., Hill, W.D., Wertkin, A. and Trojanowski, J.Q., Mapping of neurofilament epitopes in cortical and peripheral Lewy bodies, J. Neuropathol. Exp. Neurol., 50 (1991) 308.
23. [22] Tierney, M.C., Fisher, R.H., Lewis, A.J., Zorzitto, M.L., Snow, W.G., Reid, D.W. and Nieuwstraten, P., The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases, Neurology, 38 (1988) 359-364.